U-Blot® Research Grade Anti-Human ADAM9 (IMGC936)Cat. No. WA1156Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human ADAM9 (IMGC936)Cat. No. WA1156
U-Blot® Research Grade Anti-Human ACVR2B Antibody (KER-012)Cat. No. WA1155
U-Blot® Research Grade Anti-Human ACVR2A Antibody (KER-050)Cat. No. WA1154
U-Blot® Research Grade Anti-Human ACVR2A Antibody (Ab-14E1)Cat. No. WA1153
U-Blot® Research Grade Anti-Human ACVR1/ALK-2 Antibody (DS-6016a)Cat. No. WA1152
U-Blot® Research Grade Anti-Human ACTH (ALD1613)Cat. No. WA1151
U-Blot® Research Grade Anti-Human A2AR/ADORA2A Antibody (3F6-9G5)Cat. No. WA1150
U-Blot® Research Grade Anti-HRSV-A F/Fusion glycoprotein F0 Antibody (191E4#)Cat. No. WA1149
U-Blot® Research Grade Anti-HRSV-A F/Fusion glycoprotein F0 Antibody (15B3)Cat. No. WA1148
U-Blot® Research Grade Anti-HRSV Prefusion/Pre-F Antibody (RSM01)Cat. No. WA1147
U-Blot® Research Grade Anti-HRSV F/Fusion glycoprotein F0 Antibody (VIR-8190)Cat. No. WA1146
U-Blot® Research Grade Anti-HRSV F/Fusion glycoprotein F0 Antibody (RSV-002)Cat. No. WA1145